Rachel Humphrey's Insider Trades & SAST Disclosures

Rachel Humphrey's most recent trade in Pyxis Oncology Inc was a trade of 36,979 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Pyxis Oncology Inc
Rachel Humphrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 36,979 36,979 - - Stock Option (Right to Buy)
Pyxis Oncology Inc
Rachel Humphrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2024 38,741 96,805 - 0 Common Stock
Pyxis Oncology Inc
Rachel Humphrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2023 58,064 58,064 - 0 Common Stock
Pyxis Oncology Inc
Rachel Humphrey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2022 236,220 236,220 - - Stock Option (Right to Buy)
Black Diamond Therapeutics...
Rachel Humphrey Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2021 60,000 60,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades